← Open Payments lookup

AMY SEALE: Open Payments

NPI 1689134546 · BOGALUSA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$42,001 in 223 payments from 29 companies in 2025. Trend: 2023 $1,721 · 2024 $3,211 · 2025 $42,001

Speaker / faculty: $27,286Food & beverage: $7,777Travel & lodging: $5,212Consulting: $1,726
CompanyPaymentsAmount
Madrigal Pharmaceuticals56$20,443
Ardelyx, Inc.43$14,295
Takeda Pharmaceuticals U.S.A., Inc.8$1,287
Ipsen Biopharmaceuticals, Inc8$1,258
Gilead Sciences, Inc.15$1,039
ABBVIE INC.24$657
Janssen Biotech, Inc.12$445
Regeneron Healthcare Solutions, Inc.7$318
Novo Nordisk Inc4$250
Abbott Laboratories2$209

Products named: REZDIFFRA, IBSRELA, IQIRVO, Livdelzi, TREMFYA, DUPIXENT, LINZESS, SKYRIZI.

Industry payments across LA — which companies pay providers there.